| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.038 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |